Characteristics and hospital course of patients admitted for acute cardiovascular diseases during the coronavirus disease-19 outbreak

Introduction During the coronavirus disease-19 (COVID-19) outbreak in spring 2020, people may have been reluctant to seek medical care fearing infection. We aimed to assess the number, characteristics and in-hospital course of patients admitted for acute cardiovascular diseases during the COVID-19 outbreak. Methods We enrolled all consecutive patients admitted urgently for acute myocardial infarction, heart failure or arrhythmias from 1 March to 31 May 2020 (outbreak period) and 2019 (control period). We evaluated the time from symptoms onset to presentation, clinical conditions at admission, length of hospitalization, in-hospital medical procedures and outcome. The combined primary end point included in-hospital death for cardiovascular causes, urgent heart transplant or discharge with a ventricular assist device. Results A similar number of admissions were observed in 2020 (N = 210) compared with 2019 (N = 207). Baseline characteristics of patients were also similar. In 2020, a significantly higher number of patients presented more than 6 h after symptoms onset (57 versus 38%, P < 0.001) and with signs of heart failure (33 versus 20%, P = 0.018), required urgent surgery (13 versus 5%, P = 0.004) and ventilatory support (26 versus 13%, P < 0.001). Hospitalization duration was longer in 2020 (median 10 versus 8 days, P = 0.03). The primary end point was met by 19 (9.0%) patients in 2020 versus 10 (4.8%) in 2019 (P = 0.09). Conclusion Despite the similar number and types of unplanned admissions for acute cardiac conditions during the 2020 COVID-19 outbreak compared with the same period in 2019, we observed a higher number of patients presenting late after symptoms onset as well as longer and more complicated clinical courses.

[1]  O. Rodriguez-Leor,et al.  Impact of the COVID-19 pandemic on interventional cardiology activity in Spain , 2020, REC: interventional cardiology (English Edition).

[2]  J. Spratt,et al.  Effect of the COVID-19 Pandemic on ST-Segment-Elevation Myocardial Infarction Presentations and In-Hospital Outcomes. , 2020, Circulation. Cardiovascular interventions.

[3]  A. Pathak,et al.  Reduction in cardiovascular emergency admissions in Monaco during the COVID-19 pandemic , 2020, Clinical Research in Cardiology.

[4]  B. Harbaoui,et al.  Worrying decrease in hospital admissions for myocardial infarction during the COVID-19 pandemic , 2020, Archives of Cardiovascular Diseases.

[5]  F. Negri,et al.  Unpredictable Fall of Severe Emergent Cardiovascular Diseases Hospital Admissions During the COVID‐19 Pandemic: Experience of a Single Large Center in Northern Italy , 2020, Journal of the American Heart Association.

[6]  S. Themistoclakis,et al.  Urgent Pacemaker Implantation Rates in the Veneto Region of Italy After the COVID-19 Outbreak , 2020, Circulation. Arrhythmia and electrophysiology.

[7]  R. de Caterina,et al.  Reduction of hospitalizations for myocardial infarction in Italy in the COVID-19 era , 2020, European heart journal.

[8]  M. Dębski,et al.  Impact of COVID-19 pandemic on patients with ST-segment elevation myocardial infarction: Insights from a British cardiac center☆ , 2020, American Heart Journal.

[9]  S. Themistoclakis,et al.  Impact of COVID-19 epidemic on coronary care unit accesses for acute coronary syndrome in Veneto region, Italy , 2020, American Heart Journal.

[10]  F. Fedele,et al.  Reduced Rate of Hospital Admissions for ACS during Covid-19 Outbreak in Northern Italy , 2020, The New England journal of medicine.

[11]  A. Bauer,et al.  Decline of acute coronary syndrome admissions in Austria since the outbreak of COVID-19: the pandemic response causes cardiac collateral damage , 2020, European heart journal.

[12]  C. Schmidt,et al.  Reduction in ST-Segment Elevation Cardiac Catheterization Laboratory Activations in the United States During COVID-19 Pandemic , 2020, Journal of the American College of Cardiology.

[13]  C. Siu,et al.  Impact of Coronavirus Disease 2019 (COVID-19) Outbreak on ST-Segment–Elevation Myocardial Infarction Care in Hong Kong, China , 2020, Circulation. Cardiovascular quality and outcomes.